LUX
LIVE

Serial Number

79226449

Owner

Biotronik AG

Attorney

GABRIELLE S. ROTH

Filing Date

Nov 15, 2017

Add to watchlist:

No watchlists yet
View on USPTO

LUX Trademark

Serial Number: 79226449 • Registration: 5548009

LUX is a trademark filed by Biotronik AG on November 15, 2017. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

Biotronik AG (50 trademarks)

Ackerstrasse 6
Bülach CH-8180 , CH

Entity Type: 99

Trademark Details

Filing Date

November 15, 2017

Registration Date

August 28, 2018

Published for Opposition

June 12, 2018

Cancellation Date

March 14, 2025

Goods & Services

Chemical and pharmaceutical preparations for medical purposes, namely, drug preparations for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; chemical and pharmaceutical drug delivery preparations in the form of coatings for medical devices and balloons that facilitate the delivery of pharmaceuticals; chemical preparations for pharmaceutical purposes, namely, drug preparations for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; pharmaceutical preparations for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; drugs for medical purposes, namely, drugs for treating coronary artery diseases, vascular diseases, or preventing neointimal proliferation after vessel dilatation; excipients, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals for use in drug eluting balloons

Medical apparatus and instruments, namely, catheters, catheters for percutaneous coronary intervention (PCI), catheters for percutaneous transluminal coronary angioplasty (PTCA catheters), catheters for percutaneous transluminal angioplasty (PTA catheters), catheters for balloon dilatation; medical apparatus, namely, balloons for vessel dilatation, balloons for treating coronary artery diseases, vascular diseases, and preventing neointimal proliferation after vessel dilatation, coronary and peripheral balloon catheters, drug eluting balloons, drug releasing balloons, drug coated balloons, stents and drug eluting stents

Filing History

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Nov 14, 2025 INTR
NEW REPRESENTATIVE AT IB RECEIVED
Aug 7, 2025 NREP
CANCELLED SECTION 71
Mar 14, 2025 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Aug 28, 2023 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Sep 18, 2021 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Jun 5, 2021 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 28, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Dec 8, 2018 FICS
FINAL DISPOSITION PROCESSED
Dec 8, 2018 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Nov 28, 2018 FICR
REGISTERED-PRINCIPAL REGISTER
Aug 28, 2018 R.PR
NEW REPRESENTATIVE AT IB RECEIVED
Aug 24, 2018 NREP
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 12, 2018 NPUB
PUBLISHED FOR OPPOSITION
Jun 12, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Jun 8, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 23, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 23, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 23, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
May 7, 2018 CNSA
EXAMINER'S AMENDMENT ENTERED
May 7, 2018 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
May 7, 2018 GNEN
EXAMINERS AMENDMENT E-MAILED
May 7, 2018 GNEA
EXAMINERS AMENDMENT -WRITTEN
May 7, 2018 CNEA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
May 2, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
May 2, 2018 REAP
REFUSAL PROCESSED BY IB
Mar 24, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 7, 2018 RFCS
REFUSAL PROCESSED BY MPU
Mar 7, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 1, 2018 RFCR
NON-FINAL ACTION WRITTEN
Feb 28, 2018 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 13, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 9, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 8, 2018 REPR